Predictor of Surgical Failure Following Transvaginal Mesh Repair Using Minimally Invasive Prolapse System Device (MIPS)

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Sep 28

PMID 39336839

Authors

Yao-Yu Yang

Zi-Xi Loo

Kun-Ling Lin

Cheng-Yu Long

Affiliations

Soon will be listed here.

Abstract

The Minimally Invasive Prolapse System (MIPS) device, a novel single-incision transvaginal mesh, represents recent advancements in mesh technology, providing lightweight, biocompatible support for pelvic organ prolapse while reducing erosion, allowing for customization and improving surgical outcomes. This study aimed to identify factors associated with pelvic organ prolapse (POP) recurrence after transvaginal mesh (TVM) repair using the Minimally Invasive Prolapse System device. Two hundred and eighteen women with symptomatic stage II to IV POP underwent TVM. Preoperative and postoperative assessments included urinalyses and pelvic examinations using the POP quantification (POP-Q) staging system. During a follow-up period of 12-46 months, 7 of 218 (3.2%) women experienced POP recurrence. Univariate analysis was conducted to identify predictors of surgical failure, revealing no significant differences in body mass index, POP stage, or preoperative urinary symptoms between the recurrence and success groups ( > 0.05). However, functional urethral length <20 mm based on urodynamics ( = 0.011), ICI-Q scores ≥7 ( = 0.012), and the first 60 surgical cases ( = 0.018) were significant predictors of surgical failure. Multivariate logistic regression confirmed these findings. Functional urethral length <20 mm, ICI-Q scores ≥7, and limited surgical experience were significant predictors of TVM failure using the Minimally Invasive Prolapse System kit. POP recurrence after mesh repair is less likely beyond the learning curve.

References

Wu P, Wu C, Liu Y, Loo Z, Lin K, Long C . The clinical and urodynamic outcomes of single-incision mesh surgery using the Uphold system for the treatment of pelvic organ prolapse. Sci Rep. 2020; 10(1):13506. PMC: 7419285. DOI: 10.1038/s41598-020-69886-z. View

Naumann G, Husch T, Morgeli C, Kolterer A, Tunn R . Mesh-augmented transvaginal repair of recurrent or complex anterior pelvic organ prolapse in accordance with the SCENIHR opinion. Int Urogynecol J. 2020; 32(4):819-827. PMC: 8009781. DOI: 10.1007/s00192-020-04525-9. View

Zhang C, Sun Z, Yang J, Xu T, Zhu L, Lang J . Sacrocolpopexy compared with transvaginal mesh surgery: a systematic review and meta-analysis. BJOG. 2020; 128(1):14-23. DOI: 10.1111/1471-0528.16324. View

Ibinaeva I, Apolikhina I, Makhmedzhanova F, Muslimova S . [ICIQ-SF questionnaire in women with urinary incontinence]. Urologiia. 2012; (1):38-42. View

Smith F, Holman C, Moorin R, Tsokos N . Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010; 116(5):1096-100. DOI: 10.1097/AOG.0b013e3181f73729. View

Ellington D, Richter H . Indications, contraindications, and complications of mesh in surgical treatment of pelvic organ prolapse. Clin Obstet Gynecol. 2013; 56(2):276-88. PMC: 3644007. DOI: 10.1097/GRF.0b013e318282f2e8. View

Chen H, Yeh L, Chang W, Ho M . Analysis of risk factors associated with surgical failure of inside-out transobturator vaginal tape for treating urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2006; 18(4):443-7. DOI: 10.1007/s00192-006-0172-0. View

Lo T, Rom E, Harun F, Jhang L, Hsieh W, Lin Y . Anterior-apical Transvaginal Mesh (Calistar-S) for Treatment of Advanced Urogenital Prolapse: Surgical and Functional Outcomes at 1 Year. Int Urogynecol J. 2024; 35(5):1011-1019. DOI: 10.1007/s00192-024-05749-9. View

Hendrix S, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A . Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002; 186(6):1160-6. DOI: 10.1067/mob.2002.123819. View

10.

Jelovsek J, Maher C, Barber M . Pelvic organ prolapse. Lancet. 2007; 369(9566):1027-38. DOI: 10.1016/S0140-6736(07)60462-0. View

11.

Uebersax J, Wyman J, Shumaker S, McClish D, Fantl J . Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995; 14(2):131-9. DOI: 10.1002/nau.1930140206. View

12.

Tailor V, Digesu A, Swift S . Update in Transvaginal Grafts: The Role of Lightweight Meshes, Biologics, and Hybrid Grafts in Pelvic Organ Prolapse Surgery. Obstet Gynecol Clin North Am. 2021; 48(3):515-533. DOI: 10.1016/j.ogc.2021.05.006. View

13.

Olsen A, Smith V, Bergstrom J, Colling J, Clark A . Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997; 89(4):501-6. DOI: 10.1016/S0029-7844(97)00058-6. View

14.

Ker C, Lin K, Loo Z, Juan Y, Long C . Comparison of Uphold Vaginal Mesh Procedure with Hysterectomy or Uterine Preservation for the Treatment of Pelvic Organ Prolapse. Sci Rep. 2018; 8(1):9438. PMC: 6013434. DOI: 10.1038/s41598-018-27765-8. View

15.

Long C, Lo T, Wang C, Wu C, Liu C, Su J . Risk factors of surgical failure following transvaginal mesh repair for the treatment of pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2012; 161(2):224-7. DOI: 10.1016/j.ejogrb.2012.01.009. View

16.

Barber M, Walters M, Bump R . Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005; 193(1):103-13. DOI: 10.1016/j.ajog.2004.12.025. View

17.

Drutz H . Surgical management of recurrent stress urinary incontinence: A 12-year experience. Am J Obstet Gynecol. 1999; 181(6):1296-307; discussion 1307-9. DOI: 10.1016/s0002-9378(99)70368-6. View

18.

Bump R, Mattiasson A, Bo K, Brubaker L, DeLancey J, Klarskov P . The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996; 175(1):10-7. DOI: 10.1016/s0002-9378(96)70243-0. View

19.

Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M . Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology. 2006; 68(2):318-23. DOI: 10.1016/j.urology.2006.02.042. View

20.

Ng-Stollmann N, Funfgeld C, Gabriel B, Niesel A . The international discussion and the new regulations concerning transvaginal mesh implants in pelvic organ prolapse surgery. Int Urogynecol J. 2020; 31(10):1997-2002. PMC: 7497328. DOI: 10.1007/s00192-020-04407-0. View